Enrofloxacin(ENOR) antibody/antigen (BSA/OVA/KLH conjugated hapten)

anti-Enrofloxacin(ENOR) antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)

Target products collectionGo to Antibiotics diagnostics products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-SMT-58-11. BSA-Enrofloxacin(ENOR)
2. Anti-Enrofloxacin(ENOR) mouse monoclonal antibody
$2709.00
GMP-SMT-58-21. OVA-Enrofloxacin(ENOR)
2. Anti-Enrofloxacin(ENOR) mouse monoclonal antibody
$2709.00
GMP-SMT-58-31. BSA-Enrofloxacin(ENOR)
2. Anti-Enrofloxacin(ENOR) human monoclonal antibody
$2709.00
GMP-SMT-58-41. OVA-Enrofloxacin(ENOR)
2. Anti-Enrofloxacin(ENOR) human monoclonal antibody
$2709.00
GMP-SMT-58-Ag-1BSA-Enrofloxacin(ENOR)$756.00
GMP-SMT-58-Ag-2OVA-Enrofloxacin(ENOR)$756.00
GMP-SMT-58-Ab-1Anti-Enrofloxacin(ENOR) mouse monoclonal antibody$1953.00
GMP-SMT-58-Ab-2Anti-Enrofloxacin(ENOR) human monoclonal antibody$1953.00

Size: 1mg | 10mg | 100mg



Product Description


BSA-Enrofloxacin(ENOR)

Cat No.GMP-SMT-58-Ag-1
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates BSA-Enrofloxacin(ENOR) with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Enrofloxacin(ENOR) had been validated with our anti-Hapten antibody Anti-Enrofloxacin(ENOR) mouse monoclonal antibody via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
Formulation & ReconstitutionLyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


OVA-Enrofloxacin(ENOR)

Cat No.GMP-SMT-58-Ag-2
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates OVA-Enrofloxacin(ENOR) with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Enrofloxacin(ENOR) had been validated with our anti-Hapten antibody Anti-Enrofloxacin(ENOR) mouse monoclonal antibody via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
Formulation & ReconstitutionLyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Anti-Enrofloxacin(ENOR) mouse monoclonal antibody

Cat No.GMP-SMT-58-Ab-1
Host of AntibodyMouse IgG
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Lateral flow immunoassay (LFIA);
ELISA IC50 (ppb)0.1-0.3
Products descriptionThe anti-Hapten antibody against hapten Enrofloxacin(ENOR) had been validated with our hapten hapten-carrier conjugates BSA-Enrofloxacin(ENOR) via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
Formulation & ReconstitutionLyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Anti-Enrofloxacin(ENOR) human monoclonal antibody

Cat No.GMP-SMT-58-Ab-2
Host of AntibodyHuman IgG1
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Lateral flow immunoassay (LFIA);
ELISA IC50 (ppb)0.1-0.3
Products descriptionThe anti-Hapten antibody against hapten Enrofloxacin(ENOR) had been validated with our hapten hapten-carrier conjugates BSA-Enrofloxacin(ENOR) via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
Formulation & ReconstitutionLyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Biomarker Information


    Serial Number: S001

    Artificial Intelligence (AI) is a cutting-edge field of computer science that simulates human intelligence in machines. The primary goal of AI is to develop intelligent systems capable of performing tasks that typically require human cognition. These tasks include understanding natural language, recognizing patterns, making decisions, and learning from experience. AI has made significant advancements, particularly in recent years, and its applications are now prevalent in various sectors, from healthcare to finance, transportation, and entertainment.

    Serial Number: S002

    AI is powered by algorithms and data. Algorithms are sets of rules and instructions that enable machines to process and analyze information. Data, on the other hand, provides the raw material for AI systems to learn and make decisions. The process of AI involves feeding data into algorithms, enabling machines to recognize patterns and generate insights. With the accumulation of more data and continuous learning, AI systems improve their performance over time.

    Serial Number: S003

    Machine Learning (ML), a subset of AI, focuses on developing algorithms that allow systems to learn from data. One of the most influential breakthroughs in AI and ML is deep learning, a subfield that uses artificial neural networks to model and process complex data. Deep learning has propelled advancements in image and speech recognition, natural language understanding, and more.

    Serial Number: S004

    AI's impact is far-reaching. In healthcare, it aids in diagnosing diseases, predicting patient outcomes, and drug discovery. AI-driven tools can analyze medical images with high precision, providing doctors with valuable insights. In finance, AI is used for risk assessment, fraud detection, algorithmic trading, and customer service. Autonomous vehicles rely on AI to navigate and make real-time decisions, contributing to the development of self-driving cars.

    Serial Number: S005

    However, with the rapid growth of AI, ethical considerations have become a crucial aspect of its development and deployment. Concerns about bias in AI algorithms, data privacy, and job displacement have emerged. It is essential to strike a balance between innovation and ethical use. To address these issues, various organizations and governments are working on developing guidelines and regulations for AI technologies.

    Serial Number: S006

    One important aspect of AI is that it is not autonomous but rather a tool created and controlled by humans. This means that AI systems can inherit human biases present in the data they are trained on, which raises concerns about fairness and discrimination. Efforts are being made to develop AI models that are more transparent and accountable, reducing the risk of bias and unethical behavior.

    Serial Number: S007

    Looking to the future, AI has the potential to revolutionize the way we live and work. Researchers are striving to develop Artificial General Intelligence (AGI), which would be capable of understanding and performing any intellectual task that a human can do. While AGI is a long-term goal, its achievement would have profound implications for society, posing questions about ethics, labor markets, and governance.

    Serial Number: S008

    AI's impact on society is multifaceted. On one hand, it offers the promise of solving complex problems, increasing efficiency, and enhancing our daily lives. On the other hand, it raises challenges such as automation of jobs, ethical dilemmas, and the potential misuse of AI technologies for harmful purposes.

    Serial Number: S009

    To harness the potential of AI while mitigating risks, ongoing research, interdisciplinary collaboration, and responsible practices are essential. Governments, industries, and academic institutions must work together to create ethical frameworks, guidelines, and regulations for AI development and deployment. These measures are crucial to ensure that AI benefits humanity without compromising ethical standards and societal well-being.

    Serial Number: S010

    In summary, artificial intelligence represents a groundbreaking advancement in technology with wide-ranging applications across numerous industries. It has the potential to bring about positive transformations in various aspects of our lives, but it also poses significant challenges that require thoughtful consideration and responsible management.

    This comprehensive overview provides a detailed understanding of artificial intelligence, addressing its core concepts, applications, ethical concerns, and the path forward for its responsible development and deployment.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.